Precision BioSciences, Inc. (DTIL)

Precision BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	85.9	116.68	189.58	143.66	89.8
Short-Term Investments	0.41	-	-	-	-
Cash & Short-Term Investments	86.31	116.68	189.58	143.66	89.8
Cash Growth	-26.02%	-38.45%	31.96%	59.98%	-50.36%
Accounts Receivable	1.7	0.9	0.72	0.49	10
Receivables	1.7	12.8	0.72	0.49	10
Prepaid Expenses	6.44	5.98	6.03	17.43	5.76
Other Current Assets	0.54	0.91	2.78	0.17	0
Total Current Assets	94.99	136.36	199.11	161.75	105.56
Property, Plant & Equipment	10.18	14.6	13.78	29.33	41.5
Long-Term Investments	3.21	3.21	4.75	6.84	-
Other Intangible Assets	0.62	0.4	0.73	2.05	1.37
Other Long-Term Assets	22.79	0.23	12.57	4.64	1.72
Total Assets	136.39	159.78	238.17	211.5	150.16
Accounts Payable	1.31	2.97	0.65	1.14	0.79
Accrued Expenses	7.2	6.54	6.93	10.79	9.01
Short-Term Debt	-	22.41	-	-	-
Current Portion of Leases	1.32	1.13	1.68	1.82	1.93
Current Unearned Revenue	2.96	12.04	46.19	21.24	30.24
Other Current Liabilities	2.19	4.9	4.21	0.98	0.85
Total Current Liabilities	14.98	49.99	59.66	35.98	42.83
Long-Term Debt	22.32	-	22.22	2.48	-
Long-Term Leases	6.4	7.72	1.06	4.81	8.59
Long-Term Unearned Revenue	33.3	83.08	92.87	77.02	53.93
Other Long-Term Liabilities	2.99	0.13	1.92	0.04	0.39
Total Liabilities	80	140.92	177.74	120.33	105.73
Common Stock	0	0	0	-	-
Additional Paid-In Capital	539.81	509.44	489.7	408.8	331.45
Retained Earnings	-482.46	-489.63	-428.31	-316.68	-286.07
Treasury Stock	-0.95	-0.95	-0.95	-0.95	-0.95
Total Common Equity	56.39	18.86	60.43	91.17	44.43
Shareholders' Equity	56.39	18.86	60.43	91.17	44.43
Total Liabilities & Equity	136.39	159.78	238.17	211.5	150.16
Total Debt	30.05	31.27	24.96	9.11	10.52
Net Cash (Debt)	56.27	85.41	164.62	134.55	79.28
Net Cash Growth	-34.12%	-48.12%	22.35%	69.72%	-56.17%
Net Cash Per Share	8.17	22.23	56.19	68.78	45.71
Filing Date Shares Outstanding	10.48	6.92	3.71	2.03	1.9
Total Common Shares Outstanding	8.2	4.16	3.7	2.03	1.76
Working Capital	80.01	86.37	139.44	125.77	62.74
Book Value Per Share	6.87	4.53	16.34	44.91	25.29
Tangible Book Value	55.77	18.46	59.7	89.12	43.05
Tangible Book Value Per Share	6.80	4.43	16.14	43.90	24.51
Machinery	18.7	19.38	20.78	22.93	25.3
Construction In Progress	0.01	0.07	0.52	3.04	1.89
Leasehold Improvements	12.03	11.95	11.95	22.78	26.58

Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q